GB202108387D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: GB202108387D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2021-06-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2108387.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Oxford Biotherapeutics Ltd

Original Assignee

Oxford Biotherapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2021-06-11

Filing date

2021-06-11

Publication date

2021-07-28

2021-06-11 Application filed by Oxford Biotherapeutics Ltd filed Critical Oxford Biotherapeutics Ltd

2021-06-11 Priority to GBGB2108387.8A priority Critical patent/GB202108387D0/en

2021-07-28 Publication of GB202108387D0 publication Critical patent/GB202108387D0/en

2022-05-19 Priority to CA3219316A priority patent/CA3219316A1/en

2022-05-19 Priority to AU2022282609A priority patent/AU2022282609A1/en

2022-05-19 Priority to PCT/GB2022/051256 priority patent/WO2022248835A1/en

2022-05-19 Priority to JP2023571224A priority patent/JP2024521667A/en

2022-05-19 Priority to BR112023023831A priority patent/BR112023023831A2/en

2022-05-19 Priority to IL308545A priority patent/IL308545A/en

2022-05-19 Priority to US18/562,921 priority patent/US20240254238A1/en

2022-05-19 Priority to MX2023013574A priority patent/MX2023013574A/en

2022-05-19 Priority to KR1020237039652A priority patent/KR20240013732A/en

2022-05-19 Priority to EP22726279.7A priority patent/EP4346882A1/en

Status Ceased legal-status Critical Current

Links

GBGB2108387.8A 2021-05-26 2021-06-11 Pharmaceutical composition Ceased GB202108387D0 (en)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
GBGB2108387.8A GB202108387D0 (en)	2021-06-11	2021-06-11	Pharmaceutical composition
EP22726279.7A EP4346882A1 (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
JP2023571224A JP2024521667A (en)	2021-05-26	2022-05-19	Combination medicine comprising an anti-CD205 antibody and an immune checkpoint inhibitor
AU2022282609A AU2022282609A1 (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
PCT/GB2022/051256 WO2022248835A1 (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
CA3219316A CA3219316A1 (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
BR112023023831A BR112023023831A2 (en)	2021-05-26	2022-05-19	METHODS, PHARMACEUTICAL COMBINATION, ANTIBODY OR ANTIGEN BINDING PORTION THEREOF
IL308545A IL308545A (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
US18/562,921 US20240254238A1 (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
MX2023013574A MX2023013574A (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor.
KR1020237039652A KR20240013732A (en)	2021-05-26	2022-05-19	Pharmaceutical combination comprising an anti-CD205 antibody and an immune checkpoint inhibitor

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2108387.8A GB202108387D0 (en)	2021-06-11	2021-06-11	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
GB202108387D0 true GB202108387D0 (en)	2021-07-28

Family

ID=76954562

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2108387.8A Ceased GB202108387D0 (en)	2021-05-26	2021-06-11	Pharmaceutical composition

Country Status (1)

Country	Link
GB (1)	GB202108387D0 (en)

2021
- 2021-06-11 GB GBGB2108387.8A patent/GB202108387D0/en not_active Ceased

Similar Documents

Publication	Publication Date	Title
GB202019241D0 (en)	2021-01-20	Pharmaceutical composition
IL304290A (en)	2023-09-01	Pharmaceutical composition
GB201911517D0 (en)	2019-09-25	Pharmaceutical composition
IL300090A (en)	2023-03-01	Pharmaceutical compositions comprising venglustat
PL3908321T3 (en)	2024-03-25	Pharmaceutical composition
IL285728A (en)	2021-10-31	Pharmaceutical composition
PL3949952T3 (en)	2024-10-14	Pharmaceutical composition
GB202208464D0 (en)	2022-07-27	Pharmaceutical composition
GB202104224D0 (en)	2021-05-12	Pharmaceutical composition
GB202018068D0 (en)	2020-12-30	Pharmaceutical composition
GB202010340D0 (en)	2020-08-19	Pharmaceutical composition
GB202019335D0 (en)	2021-01-20	Pharmaceutical compositions
GB202109271D0 (en)	2021-08-11	Pharmaceutical composition
GB202108387D0 (en)	2021-07-28	Pharmaceutical composition
GB202107518D0 (en)	2021-07-07	Pharmaceutical composition
GB202105858D0 (en)	2021-06-09	Pharmaceutical composition
GB202105462D0 (en)	2021-06-02	Pharmaceutical composition
GB202105047D0 (en)	2021-05-26	Pharmaceutical composition
GB202105049D0 (en)	2021-05-26	Pharmaceutical composition
GB202102095D0 (en)	2021-03-31	Pharmaceutical composition
GB202102100D0 (en)	2021-03-31	Pharmaceutical composition
GB202101638D0 (en)	2021-03-24	Pharmaceutical composition
GB202101640D0 (en)	2021-03-24	Pharmaceutical composition
GB202101634D0 (en)	2021-03-24	Pharmaceutical composition
GB202101123D0 (en)	2021-03-10	Pharmaceutical composition

Legal Events

Date	Code	Title	Description
2023-01-04	AT	Applications terminated before publication under section 16(1)